CLASS II ONGOING Device recall · Reported 6 Apr 2022 · FDA Enforcement Report

cobas LiatSystem, respiratory virus panel nucleic acid recalled

Roche Molecular Systems is recalling cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number, distributed nationwide in the US. The recall was initiated on 16 Nov 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 07613336100097; Serial Numbers: 16333, 16454, 16688, 16695, 16871, 16914, 17048, 17266, 19924, 18094, 18323, 18357, 17116, 17086
Quantity recalled14 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0828-2022
FDA event ID
89643
Recalling firm
Roche Molecular Systems, Branchburg, NJ
Classification
Class II
Status
Ongoing
Recall initiated
16 Nov 2021
FDA classified
28 Mar 2022
Reported
6 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

16 Nov 2021Recall initiated by company
28 Mar 2022Classified by FDA+132 days
6 Apr 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Roche has identified a small number of cobas Liat analyzer units that have consistently high noise levels (background signal) originating from the amber detector (used for Influenza B detection). This noise increases the probability of false positive Influenza B results.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number 07341920190

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of CO, IL, IN, KY, MI, NC, and TX. The countries of Cyprus, Spain, and Hong Kong.

Nationwide ColoradoIllinoisIndianaKentuckyMichiganNorth CarolinaTexas

Questions about this recall

Is cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number recalled?

Yes. Roche Molecular Systems recalled cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number on 16 Nov 2021. The recall is Class II and its status is Ongoing. Recall number Z-0828-2022.

Why was it recalled?

Roche has identified a small number of cobas Liat analyzer units that have consistently high noise levels (background signal) originating from the amber detector (used for Influenza B detection). This noise increases the probability of false positive Influenza B results.

Which lots are affected?

UDI: 07613336100097; Serial Numbers: 16333, 16454, 16688, 16695, 16871, 16914, 17048, 17266, 19924, 18094, 18323, 18357, 17116, 17086

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of CO, IL, IN, KY, MI, NC, and TX. The countries of Cyprus, Spain, and Hong Kong.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Molecular Systems

All 42

Other CPAP & Ventilators recalls

All 552